Pfizer is buying Lake Forest-based Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business. Pfizer Inc. will pay $90 per share in cash. The companies put the deal’s enterprise value at about $17 billion.
Both companies’ boards unanimously approved the transaction, which is targeted to close in the second half of the year.
(link below)
http://chicago.suntimes.com/business/7/71/346391/pfizer-buying-hospira-15-23-billion
No comments:
Post a Comment